Clinical Trial Update: Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer [Phase 2]

View source ↗

Summary

This phase 2 trial evaluated adjuvant chemoradiotherapy with interferon alfa in patients with resected pancreatic cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED